It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: GoldGlobal
Pharmacies in the eastern Chinese city of Nanjing have been banned from selling all fever and cough medicine in the hope that residents with fever or coughing will seek treatment in hospitals instead, Nanjing's propaganda department posted on its official Weibo account.
This follows similar policy in the eastern city of Hangzhou, according to the statement.
Meanwhile in Beijing, pharmacies are being urged to register all customers who buy fever and cough medicine.
They are required to register their names, addresses, ID card numbers and contact information, as well as the symptoms, according to state-run news agency Xinhua.
via CNN
originally posted by: Necrose
originally posted by: Adphil28
a reply to: Necrose
Still linear?
Linear decline, especially outside Hubei, yes.
NONE of us know what's going to happen or what's going on.
I doubt Beijing actually has any real grasp on the number of infected or dead at this point.
There isn't a winning opinion here
virologyj.biomedcentral.com...
Jimenez-Guardeño, Nieto-Torres [18] is the only group to have shown that E is a determinant of SARS-CoV pathogenesis in vivo. By infecting mice with recombinant SARS-CoV viruses, they demonstrated that E caused syntenin to be redistributed to the cytoplasm where it triggered an overexpression of inflammatory cytokines. This would give rise to an exacerbated immune response, resulting in tissue damage, oedema, and culminate in the characteristic acute respiratory distress syndrome (ARDS).
NEW: Doctor in Japan diagnosed with coronavirus; it's unknown how he was infected
retrovirology.biomedcentral.com...
The frantic play of the concealed HIV envelope cytoplasmic tail
Mature Env thus forms a cage-like structure with an interior void; this cage-like structure is believed to restrict antibody access
This substantial glycosylation is believed to ensure correct protein folding and to favor immune escape by providing a glycan shield against neutralizing antibodies.
As the disease progresses, viral strains lose potential N-glycosylation sites (PNGs) and display notably reduced glycosylation; these strains are consequently less well shielded from neutralizing antibodies.
Nonetheless, such viral strains appear late during infection, concomitantly with the decline in CD4+ T cell counts, such that the immune system is unable to trigger an efficient B-cell response; consequently, evading the immune system is no longer necessary